Showing results (171-180 of 258) with videos related to
Sort By:
Pageof 26
Heart Rhythm|December 3, 2014
Reverse ventricular remodeling and long-term survival in patients undergoing cardiac resynchronization with surgically versus percutaneously placed left ventricular pacing leadsJohn Rickard, Douglas R Johnston, Joel Price, et al.Pacing and Clinical Electrophysiology : PACE|May 27, 2020
Proarrhythmic effects from competitive atrial pacing and potential programming solutionsSoJin Y Wass, Mohamed Kanj, Kenneth Mayuga, et al.Pacing and Clinical Electrophysiology : PACE|March 1, 2005
Improved extraction of ePTFE and medical adhesive modified defibrillation leads from the coronary sinus and great cardiac veinBruce L Wilkoff, Peter H Belott, Charles J Love, et al.The American Journal of Cardiology|October 1, 2003
QRS duration and prediction of mortality in patients undergoing risk stratification for ventricular arrhythmiasVidyasagar Kalahasti, Vijay Nambi, David O Martin, et al.Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|July 30, 2004
Evaluation of ventricular synchrony using novel Doppler echocardiographic indices in patients with heart failure receiving cardiac resynchronization therapyJing Ping Sun, Edward Chinchoy, Erwan Donal, et al.Heart Rhythm|May 18, 2010
Cardiac implantable electronic device infections: presentation, management, and patient outcomesKhaldoun G Tarakji, Eric J Chan, Daniel J Cantillon, et al.Journal of the American College of Cardiology|April 24, 2010
Long-term reverse remodeling with cardiac resynchronization therapy: results of extended echocardiographic follow-upDavid Verhaert, Richard A Grimm, Chirapa Puntawangkoon, et al.Heart Rhythm|July 19, 2021
Infectious consequences of hematoma from cardiac implantable electronic device procedures and the role of the antibiotic envelope: A WRAP-IT trial analysisKhaldoun G Tarakji, Panagiotis Korantzopoulos, Francois Philippon, et al.JACC. Clinical Electrophysiology|March 23, 2024
Mortality Benefit Among Primary Prevention Implantable Cardioverter-Defibrillator Recipients on Contemporary Heart Failure TreatmentAamir Ahmed, Angelo Auricchio, Suneet Mittal, et al.Journal of Medical Economics|October 12, 2020
Economic implications of adding a novel algorithm to optimize cardiac resynchronization therapy: rationale and design of economic analysis for the AdaptResponse trialGerasimos Filippatos, Xiaoxiao Lu, Stelios I Tsintzos, et al.Pageof 26